Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Yarur, Andres J, Maria T Abreu, Parakkal Deepak, Poonam Beniwal-Patel, Konstantinos Papamichael, Byron Vaughn, Alexandra Bruss, et al. 2023. “Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.”. The American Journal of Gastroenterology 118 (11): 2005-13.